期刊文献+

循经刮痧配合氯雷他定治疗持续性变应性鼻炎的临床研究 被引量:12

Clinical Study on the Treatment of Persistent Allergic Rhinitis by Scraping Therapy Along Meridian Combined with Loratadine
下载PDF
导出
摘要 目的探讨循经刮痧配合氯雷他定治疗持续性变应性鼻炎(PAR)肺经伏热证的临床疗效。方法选取2015年3月至2016年9月南京中医药大学附属医院耳鼻咽喉科门诊收治的PAR属肺经伏热证患者60例,随机分为氯雷他定对照组和刮痧配合氯雷他定治疗组,每组各30例,2组患者均治疗4周,采用鼻部症状总评分(TNNS)、视觉模拟量表(VAS)评分、RQLQ评分、总IgE、IL-4水平和总有效率对临床疗效进行评价。结果治疗4周后2组患者TNNS、VAS、RQLQ评分及总IgE、IL-4值均明显降低(P<0.01),治疗组在改善VAS、RQLQ评分、IL-4水平方面均优于对照组(P<0.01),治疗组临床疗效和远期随访效果优于对照组(P<0.05~0.01)。结论刮痧配合氯雷他定是治疗变应性鼻炎的有效方法,有良好的远期效果。 OBJECTIVE To study the clinical effect of scraping therapy along meridian combined with loratadine in the treatment of persistent allergic rhinitis(PAR)caused by heat accumulation in lung meridian.METHODS Sixty patients with PAR caused by heat accumulation in lung meridian included in the affiliated hospital of Nanjing University of Chinese Medicine from March,2015 to September,2016 were selected and randomly divided into the loratadine control group,the scraping and loratadine combination group,30 cases in each group.Patients in both groups were treated for 4 weeks.Clinical curative effect was evaluated by total nasal symptoms scores(TNSS),visual analog scale(VAS),RQLQ score,total IgE,IL-4 level and total effective rate.RESULTS TNNS,VAS,RQLQ score,total IgE and IL-4 level all decreased in two groups after 4 weeks' treatment(P<0.01).The treatment group was better than the control group in improving VAS,RQLQ score and IL-4 level(P<0.01).And the treatment group was better than the control group in clinical effect and long-term follow-up effect(P<0.05~0.01).CONCLUSIONS Scraping and loratadine combination therapy is an effective treatment for allergic rhinitis and has satisfied long-term effect.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2017年第6期583-586,共4页 Journal of Nanjing University of Traditional Chinese Medicine
基金 江苏省中医药管理局项目(JD201517)
关键词 循经刮痧 变应性鼻炎 氯雷他定 总IGE 白介素4 scraping therapy along meridian allergic rhinitis loratadine total IgE interleukin 4
  • 相关文献

参考文献2

二级参考文献147

  • 1沈朝斌,顾珺,林千里,戴强,陈卫平,吕红,舒志军.玉屏风散与T细胞亚型表达的Meta分析[J].上海中医药杂志,2004,38(11):59-61. 被引量:18
  • 2顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1709
  • 3韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:402
  • 4Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update ( in collaboration with the World Health Organization, GAELEN and AllerGen). Allergy, 2008, 63(Suppl 86) :8-160.
  • 5Alvarez-Cuesta E, Bousquet J, Canoniea GW, et al. Standards for practical allergen-specific immunotherapy. Allergy, 2006, 61 ( Suppl 82) : 1-20.
  • 6Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy, 2007, 62 : 367-372.
  • 7中华医学会耳鼻咽喉科学分会,中华耳鼻咽喉科杂志编辑委员会.变应性鼻炎诊断标准及疗效评定标准(1997年修订,海口)[J] .中华耳鼻咽喉科杂志,1998,33: 134-135.
  • 8中华耳鼻咽喉头颈外科杂志编委会,中华医学会耳鼻咽喉科学分会.儿童阻塞性睡眠呼吸暂停低通气综合征诊疗指南草案(乌鲁木齐)[J].中华耳鼻喉头颈外科杂志,2007,42(2):83-5.
  • 9Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) [ J]. Allergy, 2008, 63 Suppl 86: 8-160. DOI: 10.1111/j. 1398- 9995. 2007. 01620. x.
  • 10Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in china [ J]. Int Arch Allergy Immunol, 2009, 149 ( 1 ) : 47-57, DOI: 10. 1159/ 000176306.

共引文献2109

同被引文献203

引证文献12

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部